메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한피부과학회 Annals of Dermatology Annals of Dermatology 제26권 제2호
발행연도
2014.1
수록면
172 - 176 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Although intralesional methotrexate (MTX) isan effective, nonsurgical treatment of keratoacanthoma (KA),there have not been many reports of on the MTX treatmentfor KA in Korea. Objective: The purpose of this study was toevaluate the clinical efficacy of the intralesional MTX for thetreatment of KA in Korean patients. Methods: We retrospectivelystudied seven patients with KA who receivedintralesional injection of MTX in our department. Theefficacy was evaluated based on the physician assessment. Our review also included the cases of KA treated withintralesional MTX in Korean patients from the previous reports. We then analyzed the therapeutic regimens in the Koreanpatients by comparing them with the Caucasian patients. Results: We identified 11 cases of Korean KA patients treatedwith an intralesional MTX, including seven from ourinstitution and four from the Korean literature. Ten of the 11patients (91%) showed a complete resolution with anintralesional MTX. No adverse events were observed duringthe treatment and the follow-up periods. No recurrence wasfound during the follow-up. In therapeutic analysis, theKorean patients required 2 to 7 injections (mean 4.6 injections)to achieve a tumor resolution with the mean time to clearingat 7.6 weeks. Conclusion: Intralesional MTX can be aneffective and safe non-operative treatment modality for mostKoreans with KA.

목차

등록된 정보가 없습니다.

참고문헌 (16)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0